Eric Lefkofsky + Tempus
Tempus is a diagnostics company based in Chicago, and it was founded by its CEO, Eric Lefkofsky, in 2015. It is presented the initial look at Tempus ONE, a transportable, artificial intelligence-powered, voice enabled machine in which oncologists can ask for information regarding the clinical trial options, molecular test results, as well as treatment results for their patients. According to Eric Lefkofsky, Tempus Founder and CEO, the cube-shaped machine which can be put in the doctor’s pocket or placed on a desk is a result of some years of R&D at his own company, and it is now obtainable to choose oncologists via a beta launch. Tempus is a body covered under the Health Insurance Portability as well as Accountability Act (HIPAA). As a result, all of the information is rubbed of patient name, address date of birth, along with any additional information point which can make an individual to be identified.
Early on, his excellent thought was that the platform was supposed to apply to a wide range of patient information. That’s why the platform was intended to be what the company terms “disease agnostic.” This means that it can be used for patients who are suffering from various types of sicknesses, including depression, cancer, cardiovascular disease, diabetes, as well as Covid-19. There are around 7,500 oncologists on this platform and about 2,000 workers. The company is as well working in partnership with some healthcare institutions, through which it collects unstructured and structured patient data from warehouses or straight from the EHR.
